๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

EarthFirst Technologies signs Canadian agreement


Publisher
Elsevier Science
Year
2004
Weight
36 KB
Volume
2004
Category
Article
ISSN
1351-4180

No coin nor oath required. For personal study only.

โœฆ Synopsis


Quest's ligand technology is being used by Pfizer for the process development and manufacture of new therapeutic compounds. The relationship covers a range of Chiral Quest's catalysts and ligands. This achievement further supports and develops Chiral Quest's goal of becoming a leading, high value technology provider of products and services to the chiral therapeutics industry.


๐Ÿ“œ SIMILAR VOLUMES


GE and Umicore sign technology agreement
๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› Elsevier Science โš– 59 KB

Brazil using sugarcane-derived ethanol as feedstock.

Brimac, Plymouth Technology sign pan-Eur
๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 65 KB

## Dividends โ€ข Donaldson Co's board of directors has increased its quarterly common stock cash dividend by 10%, marking the company's 22nd consecutive year of dividend increases. The board declared a regular cash dividend of US$0.11 per share, payable on 14 March 2008 to shareholders of record on

BASF signs R&D agreement with NanoMateri
๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› Elsevier Science โš– 37 KB

dioxide emissions by 15%. Hydrogen fuel cells are also a potential growing market. Companies operating in this market include PolyFuel. QuantumSphere is developing fuel cell catalysts which use alternative metals such as nickel instead of the more commonly used platinum. Catalytic Solutions and Nano